header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-PUB-181024-5
Inhibition of TBK1/IKKε Promotes Regeneration of Pancreatic β-cells
Xu, J., Jia, Y.F., Tapadar, S., Weaver, J.D., Raji, I.O., Pithadia, D.J., Javeed, N., García, A.J., Choi, D.S., Matveyenko, A.V., Oyelere, A.K., Shin, C.H.
Date: 2018
Source: Scientific Reports   8: 15587 (Journal)
Registered Authors: Pithadia, Deeti J., Shin, Chong, Xu, Jin
Keywords: none
MeSH Terms: none
PubMed: 30349097 Full text @ Sci. Rep.
FIGURES
ABSTRACT
β-cell proliferation induction is a promising therapeutic strategy to restore β-cell mass. By screening small molecules in a transgenic zebrafish model of type 1 diabetes, we identified inhibitors of non-canonical IκB kinases (IKKs), TANK-binding kinase 1 (TBK1) and IκB kinase ε (IKKε), as enhancers of β-cell regeneration. The most potent β-cell regeneration enhancer was a cinnamic acid derivative (E)-3-(3-phenylbenzo[c]isoxazol-5-yl)acrylic acid (PIAA), which, acting through the cAMP-dependent protein kinase A (PKA), stimulated β-cell-specific proliferation by increasing cyclic AMP (cAMP) levels and mechanistic target of rapamycin (mTOR) activity. A combination of PIAA and cilostamide, an inhibitor of β-cell-enriched cAMP hydrolyzing enzyme phosphodiesterase (PDE) 3, enhanced β-cell proliferation, whereas overexpression of PDE3 blunted the mitogenic effect of PIAA in zebrafish. PIAA augmented proliferation of INS-1β-cells and β-cells in mammalian islets including human islets with elevation in cAMP levels and insulin secretion. PIAA improved glycemic control in streptozotocin (STZ)-induced diabetic mice with increases in β-cell proliferation, β-cell area, and insulin content in the pancreas. Collectively, these data reveal an evolutionarily conserved and critical role of TBK1/IKKε suppression in expanding functional β-cell mass.
ADDITIONAL INFORMATION